FDA says Boston Scientific initiates recall of stent for leg arteries

06/20/2011 | Wall Street Journal, The

The FDA said Boston Scientific has voluntarily pulled from the market its Innova self-expanding stent, which is designed to treat lesions in leg arteries, after receiving reports of deployment problems that might lead to vessel wall injury and emergency surgery, among other adverse events. Boston Scientific, which markets the device outside the U.S., already has informed consumers about the stent problem.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD